Some visit links earn us a commission.
Quick verdict
LifeMD is the better pick for most patients on overall scoring. Mature publicly-traded telehealth with rare direct-supply deals from both Novo Nordisk and Eli Lilly. Membership is $75 the first month then $149/mo ongoing. The Wegovy pill is $149/mo at starter doses and $299/mo at full doses. Steady-state total runs about $448/mo (starter months about $298, first month $224). Wegovy injection runs higher and Zepbound vials from $349. Insurance navigation included. Opt-in money-back guarantee: stay enrolled 12 months and lose at least 10% body weight, or you're eligible for a refund per posted terms.
That said, Embla wins on specific dimensions. Embla is the closest thing the US market has to a Noom-meets-Calibrate hybrid that actually leans into the medication. Heavy behavioral coaching, branded-first prescribing, structured 12-month curriculum. Best for buyers who want the program to do half the work.
Side-by-side
| Embla | LifeMD | |
|---|---|---|
| Starts from | $249/mo (+ med separate) | $448/mo (+ med separate) |
| Monthly cost gap | Embla is $49/mo cheaper than LifeMD | |
| Lock-in | 12-mo lock-in | Month-to-month |
| Time to prescription | 7 days | 2 days |
| Consultation type | Live | Async |
| Affiliate network | Impact | Impact |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Embla | LifeMD | |
|---|---|---|
| Pricing transparency | 4/10 | 8/10 |
| Cancellation terms | 7/10 | 7.5/10 |
| Onboarding experience | 6/10 | 8.5/10 |
| Medication options | 7/10 | 9/10 |
| Member reviews | 9.2/10 | 8.2/10 |
When to choose Embla
Best for structured behavior support
Patients who tried meds-only and bounced, and want a structured behavior program alongside GLP-1.
Embla wins on member reviews and runs $49/mo cheaper than LifeMD at the entry tier ($249 vs $298). Over a year that's $588 you keep. The caveat: Buyers who only want the script and find coaching content patronizing.
When to choose LifeMD
Best for insurance plus lifestyle support
Mainstream patients who want insurance navigation plus the option to cash-pay for branded GLP-1 at near-NovoCare/LillyDirect rates without leaving the platform.
LifeMD wins on pricing transparency, cancellation terms, onboarding experience, medication options on the dimensional scoring. The caveat: Patients chasing the absolute cheapest compounded option or wanting a pure cash-only flat rate. Note also: Publicly traded NASDAQ:LFMD with formal pharmaceutical supply agreements
If cost is your main filter
Embla is the cheaper monthly: $249 all-in vs $298 for LifeMD. That's $49 a month or $588a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $147 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Embla (12-mo lock-in) and LifeMD (month-to-month) sit at different cancellation tiers. If you're first-time on a GLP-1 and unsure how you'll tolerate it, LifeMD's easier cancellation is the safer trial.
FAQ
Is Embla cheaper than LifeMD?
Can I switch from Embla to LifeMD mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
